214 related articles for article (PubMed ID: 8799191)
1. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.
Wieland K; Zuurmond HM; Krasel C; Ijzerman AP; Lohse MJ
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9276-81. PubMed ID: 8799191
[TBL] [Abstract][Full Text] [Related]
2. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
Kikkawa H; Isogaya M; Nagao T; Kurose H
Mol Pharmacol; 1998 Jan; 53(1):128-34. PubMed ID: 9443940
[TBL] [Abstract][Full Text] [Related]
3. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor.
Hannawacker A; Krasel C; Lohse MJ
Mol Pharmacol; 2002 Dec; 62(6):1431-7. PubMed ID: 12435811
[TBL] [Abstract][Full Text] [Related]
4. Study of interaction between agonists and asn293 in helix VI of human beta(2)-adrenergic receptor.
Zuurmond HM; Hessling J; Blüml K; Lohse M; Ijzerman AP
Mol Pharmacol; 1999 Nov; 56(5):909-16. PubMed ID: 10531394
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor.
Arakawa M; Chakraborty R; Upadhyaya J; Eilers M; Reeves PJ; Smith SO; Chelikani P
Biochim Biophys Acta; 2011 Apr; 1808(4):1170-8. PubMed ID: 21262196
[TBL] [Abstract][Full Text] [Related]
6. Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions.
Gabilondo AM; Krasel C; Lohse MJ
Eur J Pharmacol; 1996 Jun; 307(2):243-50. PubMed ID: 8832227
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
Green SA; Turki J; Innis M; Liggett SB
Biochemistry; 1994 Aug; 33(32):9414-9. PubMed ID: 7915137
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
9. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
10. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.
Reiner S; Ambrosio M; Hoffmann C; Lohse MJ
J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485
[TBL] [Abstract][Full Text] [Related]
11. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
Green SA; Rathz DA; Schuster AJ; Liggett SB
Eur J Pharmacol; 2001 Jun; 421(3):141-7. PubMed ID: 11516429
[TBL] [Abstract][Full Text] [Related]
12. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase.
Fraser CM; Chung FZ; Wang CD; Venter JC
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5478-82. PubMed ID: 2840663
[TBL] [Abstract][Full Text] [Related]
14. Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor.
Swaminath G; Lee TW; Kobilka B
J Biol Chem; 2003 Jan; 278(1):352-6. PubMed ID: 12409304
[TBL] [Abstract][Full Text] [Related]
15. Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.
Pak MD; Fishman PH
J Recept Signal Transduct Res; 1996; 16(1-2):1-23. PubMed ID: 8771528
[TBL] [Abstract][Full Text] [Related]
16. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
Hwa J; Perez DM
J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
[TBL] [Abstract][Full Text] [Related]
17. Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase.
Kebabian JW; Zatz M; Romero JA; Axelrod J
Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3735-9. PubMed ID: 1059161
[TBL] [Abstract][Full Text] [Related]
18. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
Zhu SJ; Toews ML
Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
[TBL] [Abstract][Full Text] [Related]
19. Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.
Mukherjee C; Caron MG; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1975 May; 72(5):1945-9. PubMed ID: 1057183
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.
Hossain M; Rashid M; Bhuiyan MA; Nakamura T; Ozaki M; Nagatomo T
Life Sci; 2009 Aug; 85(7-8):339-44. PubMed ID: 19580817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
